Sort
130,381 grants matching “hiv”
Mass Spectrometric Detection of Drug-Resistant HIV
$848,937James Han · Ambergen, Inc · R44 · FY2008 · AI
Mass Spectrometric Detection of Drug-Resistant HIV
$848,937James Han · Ambergen, Inc · R44 · FY2009 · AI
Central Africa IeDEA
$848,891Kathryn M Anastos · Albert Einstein College Of Medicine · U01 · FY2011 · AI
HIV-1 Evolution and Functional Correlates of MTCT
$848,885Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · R01 · FY2012 · AI
Mass Spectrometric Detection of Drug-Resistant HIV
$848,857James Han · Ambergen, Inc · R44 · FY2007 · AI
Mechanisms of HIV accessory protein mediated control of NK cell function
$848,839Kiera L. Clayton · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AI
IMPROVING COMBINED BUPRENORPHINE-BEHAVIORAL TREATMENT
$848,795University Of Vermont &St Agric College · R01 · FY2001 · DA
Deciphering the impact of sex in early subtype C HIV infection and during HART
$848,786Eric Hunter · Emory University · R01 · FY2023 · AI
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$848,658Alan David Levine · Case Western Reserve University · R01 · FY2018 · DA
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$848,658Alan David Levine · Case Western Reserve University · R01 · FY2019 · DA
Focal segmental glomerulosclerosis: Treatment
$848,619Jeffrey Burnett Kopp · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors
$848,532Laurent Karl Verkoczy · San Diego Biomedical Research Institute · R01 · FY2019 · AI
HEALTH RELATED INTERVENTIONS FOR PERSONS LIVING WITH HIV
$848,470University Of California San Francisco · R01 · FY2000 · MH
Maximizing germinal centers and somatic hypermutation to HIV Env immunogens
$848,466Shane P Crotty · La Jolla Institute For Immunology · R01 · FY2017 · AI
Recombinant Vaccines for Prevention of AIDS and Other Diseases
$848,411Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
The Center for HIV RNA Studies (CRNA)
$848,386Alice Telesnitsky · University Of Michigan At Ann Arbor · P50 · FY2012 · GM
Evaluation of HIV-associated Cardiac Dysfunction in Women
$848,351Jorge R Kizer · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · HL
eCD4-Mediated Control of SIV Infection in the Brain
$848,349Michael R. Farzan · Boston Children'S Hospital · R01 · FY2024 · NS
PRDOH-ENHANCE COMPREHENSIVE HIV PREVENTION PLANNING OPPORTUNITY TO DEVELOP THE CO
$848,326Hermes R Garcia · Puerto Rico Department Of Health · U65 · FY2010 · PS
University of Miami Pediatric Perinatal HIV/AIDS Clinical Trails Unit
$848,314Gwendolyn B. Scott · University Of Miami School Of Medicine · U01 · FY2009 · AI
Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs
$848,288Kim Teversham · Careworks · U2G · FY2013 · GH
INTERVENTION TO REDUCE HIV/STD RISK IN TEEN PREGNANCY
$848,229Yale University · R01 · FY2003 · MH
Xenogeneic Stem Cell and Thymic Replacement in AIDS
$848,198Massachusetts General Hospital · P01 · FY2002 · AI
Immune interventions in SIV-infected ART-suppressed infant macaques
$848,161Ann M Chahroudi · Emory University · R01 · FY2019 · AI
Role of the microbiome in HIV vaccine induced heterogeneity
$848,148James G. Kublin · Fred Hutchinson Cancer Research Center · R01 · FY2018 · AI